Bank Of New York Mellon Corp Savara Inc Transaction History

Bank Of New York Mellon Corp

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.11 - $1.64 $56,856 - $84,004	51,222 New	51,222 $79,000
Q2 2022 Aug 15, 2022	SELL	$1.1 - $1.58 $40,203 - $57,747	-36,549 Reduced 29.78%	86,178 $131,000
Q1 2021 May 13, 2021	BUY	$1.17 - $2.33 $7,829 - $15,592	6,692 Added 5.77%	122,727 $255,000
Q4 2020 Feb 09, 2021	SELL	$1.0 - $1.47 $4,670 - $6,864	-4,670 Reduced 3.87%	116,035 $133,000
Q3 2020 Nov 12, 2020	BUY	$1.09 - $2.21 $458 - $930	421 Added 0.35%	120,705 $131,000
Q2 2020 Aug 12, 2020	BUY	$1.8 - $3.05 $75,933 - $128,664	42,185 Added 54.01%	120,284 $299,000
Q1 2020 May 06, 2020	BUY	$1.91 - $4.08 $14,472 - $30,914	7,577 Added 10.74%	78,099 $165,000
Q4 2019 Feb 14, 2020	SELL	$0.71 - $4.91 $13,650 - $94,399	-19,226 Reduced 21.42%	70,522 $315,000
Q3 2019 Nov 07, 2019	BUY	$2.16 - $3.2 $3,648 - $5,404	1,689 Added 1.92%	89,748 $237,000
Q2 2019 Aug 12, 2019	BUY	$2.37 - $11.7 $11,376 - $56,160	4,800 Added 5.77%	88,059 $208,000
Q1 2019 May 14, 2019	BUY	$6.71 - $8.6 $2,140 - $2,743	319 Added 0.38%	83,259 $614,000
Q4 2018 Feb 11, 2019	BUY	$6.27 - $10.92 $17,744 - $30,903	2,830 Added 3.53%	82,940 $628,000
Q3 2018 Nov 09, 2018	BUY	$10.49 - $12.87 $64,240 - $78,815	6,124 Added 8.28%	80,110 $0
Q2 2018 Aug 06, 2018	BUY	$8.55 - $13.76 $412,263 - $663,479	48,218 Added 187.12%	73,986 $838,000
Q1 2018 May 15, 2018	BUY	$8.99 - $14.95 $93,891 - $156,137	10,444 Added 68.15%	25,768 $236,000
Q4 2017 Feb 09, 2018	BUY	$8.26 - $16.76 $126,576 - $256,830	15,324	15,324 $227,000

128

158M

67.6K

29.4K

Ticker SVRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,043,000
Market Cap $368M
Description
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.